TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
119 hedge funds and large institutions have $1.33B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.63M
Holders
119
Holding in Top 10
3
Calls
$1.2M
Puts
$1.63M
Top Buyers
| 1 | +$69.2M | |
| 2 | +$13.8M | |
| 3 | +$13.7M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$11.6M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$7.88M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$24.2M | |
| 3 | -$21.2M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$17.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.2M |